衡力R改善眉间纹的安全性和有效性(4)
[12]Carruthers JA，Lowe NJ，Menter MA，et al.A Multicenter，Double-blind，Randomized， Placebo-controlled Study of the Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines[J]. Am Acad Dermatol，2002，46(6)：840-849.
[13]Carruthers JD， Lowe NJ， Menter MA， et al. Double-blind， placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines[J].Plast Reconstr Surg. 2003 Sep 15；112(4)：1089-1098.
[14]Carruthers A，Carruthers J，Said S.Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females[J].Dermatol Surg，2005，31(4)：414-422.
[15]ボトックスビスタ？注用50単位2012年1月(第3版)アラガン？ジャパン株式会社.
rimes PE，Shabazz D. A four-month randomized， double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types Ⅴand Ⅵ[J].Dermatol Surg，2009，35：429-436.
rin MF， Boodhoo TI， Pogoda JM et，al. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines： a meta-analysis of individual patient data from global clinical registration studies in 1678 participants[J].Am Acad Dermatol，2009，61(6)：961-970.e1-11.
onheit GD，Cohen JL.Reloxin Investigational Group.Long-term safety of repeated administrations of a new formulation of botulinum toxin type A in the treatment of glabellar lines： interim analysis from an open-label extension study[J].Am Acad Dermatol，2009，61(3)：421-425.
arruthers A，Carruthers J.A single-center，dose-comparison，pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids： safety and efficacy [J]. Am Acad Dermatol，2009，60(6)：972-979.
inder JS，Edmonson BC，Laquis SJ，et al. Skin cooling before periocular botulinum toxin A injection[J].Ophthal Plast Reconstr Surg，2002，18(6)：441-442.
]2012-04-25 [修回日期]2012-08-1, 百拇医药
[13]Carruthers JD， Lowe NJ， Menter MA， et al. Double-blind， placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines[J].Plast Reconstr Surg. 2003 Sep 15；112(4)：1089-1098.
[14]Carruthers A，Carruthers J，Said S.Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females[J].Dermatol Surg，2005，31(4)：414-422.
[15]ボトックスビスタ？注用50単位2012年1月(第3版)アラガン？ジャパン株式会社.
rimes PE，Shabazz D. A four-month randomized， double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types Ⅴand Ⅵ[J].Dermatol Surg，2009，35：429-436.
rin MF， Boodhoo TI， Pogoda JM et，al. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines： a meta-analysis of individual patient data from global clinical registration studies in 1678 participants[J].Am Acad Dermatol，2009，61(6)：961-970.e1-11.
onheit GD，Cohen JL.Reloxin Investigational Group.Long-term safety of repeated administrations of a new formulation of botulinum toxin type A in the treatment of glabellar lines： interim analysis from an open-label extension study[J].Am Acad Dermatol，2009，61(3)：421-425.
arruthers A，Carruthers J.A single-center，dose-comparison，pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids： safety and efficacy [J]. Am Acad Dermatol，2009，60(6)：972-979.
inder JS，Edmonson BC，Laquis SJ，et al. Skin cooling before periocular botulinum toxin A injection[J].Ophthal Plast Reconstr Surg，2002，18(6)：441-442.
]2012-04-25 [修回日期]2012-08-1, 百拇医药